Evidence highlights the need to re-establish quality metrics for low-density lipoprotein cholesterol (LDL-C) measurement and control. Despite the efficacy of LDL-C lowering in reducing cardiovascular disease risk, significant gaps exist in achieving recommended levels.
Read MoreA recent study published in JAMA Cardiology examines the use of percutaneous microaxial LVAD in patients with cardiogenic shock. While some analyses indicate worse outcomes compared to medical therapy and IABP, confounding variables limit conclusive findings.
Read MoreUS News & World Report has named Texas Children’s Hospital as the top hospital for pediatric cardiology and heart surgery for the seventh year in a row. The rankings, based on objective measures of hospital quality, recognize Texas Children’s Hospital’s dedication to best practices and equity.
Read More
Cleerly has been recognized with the prestigious “Best Overall AI Solution” award by AI Breakthrough. By harnessing the power of AI and non-invasive imaging, Cleerly’s digital care platform enables precise identification and treatment of heart disease at its early stages.
Read MoreThe FDA has granted approval to iTFlow, a groundbreaking software developed by Cardio Flow Design Inc., for blood flow analysis. With its ability to analyze 4D Flow MRI data, iTFlow provides healthcare professionals with precise insights into blood flow dynamics, improving diagnostic accuracy and treatment planning for cardiovascular diseases and heart conditions.
Read More